Multinational pharmaceutical firms are stepping up their marketing in domestic hypertension, hyperlipidemia, diabetes and hepatitis B markets, according to marketing sources.
In hypertension market, Novartis’s Diovan and Daewoong’s Almetec each raked 6 billion won in August sales, followed by Novartis’s Exporge with 5.9 billion won.
In August, Handok’s Amaryl and MSD’s Januvia recorded 5....
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.